The addition of two more US patents to ARANZ Medical’s portfolio of skin surface measurement products further strengthen and secure the company’s IP and product lines.
ARANZ Medical’s Silhouette solution uses innovative technology to drive better health outcomes for patients and provides considerable efficiencies over other common skin assessment solutions for clinical practice and research organizations alike.
The latest patents (9,955,910 and 10,013,527) help to secure the company’s market-leading position in automatically assessing an anatomical surface feature and securely managing information related to this.
ARANZ Medical CEO, Bruce Davey says, “Our growing portfolio of patents is testament to the unique position we hold in the area of wound and skin surface measurement. The growing awareness of the benefits of our systems, customer acceptance of our easy to use products, and the growing strength of our IP portfolio provides us with confidence to continue investing in new innovations for our product lines.”
Source: ARANZ Medical